Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na(+)/Ca(2+) exchanger

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• The mitochondrial Na(+)/Ca(2+) exchanger regulates cytosolic Ca(2+) cycling, impacting Ca(2+)-dependent processes like apoptosis.
• CGP37157, a benzothiazepine, is a widely used but suboptimal tool for studying this exchanger due to poor selectivity and lipophilicity.
• Existing limitations of CGP37157 hinder its therapeutic application and detailed physiological investigation.

Purpose of the Study:

• To synthesize novel CGP37157 analogs with improved pharmacokinetic properties, potency, and selectivity.
• To investigate the efficacy of new pyridothiazepine derivatives in regulating mitochondrial Ca(2+) clearance.
• To assess the neuroprotective potential of these new compounds.

Main Methods:

• Synthesis of pyridothiazepine derivatives by replacing the benzene ring of CGP37157 with pyridine.
• Evaluation of water solubility and lipophilicity (log P values) of the synthesized analogs.
• Assessment of the compounds' capacity to regulate mitochondrial Ca(2+) clearance and their neuroprotective effects.

Main Results:

• New pyridothiazepine derivatives exhibited improved water solubility and lower log P values compared to CGP37157.
• Some analogs demonstrated enhanced regulation of mitochondrial Ca(2+) clearance.
• The synthesized compounds retained the neuroprotective properties of the parent compound, CGP37157.

Conclusions:

• Pyridothiazepine derivatives represent promising alternatives to CGP37157 for studying mitochondrial Na(+)/Ca(2+) exchange.
• These novel compounds offer improved pharmacological profiles, including enhanced solubility and potentially greater efficacy.
• The findings support the development of new therapeutic agents targeting mitochondrial Ca(2+) homeostasis.